When a dying patient is asked to participate in a double-blind, placebo-controlled clinical trial on symptom control: The decision-making process and experiences of relatives

BACKGROUND: Placebo-controlled trials can provide evidence to inform end-of-life care, but it is contested whether asking dying patients to participate in such trials is morally justifiable. To investigate the experiences of these patients is even more complex. Therefore, proxy assessments by relati...

Descripción completa

Detalles Bibliográficos
Autores principales: van Esch, Harriëtte J, Stoppelenburg, Arianne, van Zuylen, Lia, van der Rijt, Carin CD, van der Heide, Agnes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749009/
https://www.ncbi.nlm.nih.gov/pubmed/36503315
http://dx.doi.org/10.1177/02692163221127557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749009/
https://www.ncbi.nlm.nih.gov/pubmed/36503315
http://dx.doi.org/10.1177/02692163221127557

Ejemplares similares